Knight Therapeutics announces launch of Bijuva in Canada

Knight Therapeutics announced the launch of BIJUVA capsules in Canada. BIJUVA is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause in women with an intact uterus. VMS affects 60% to 80% of women entering menopause and are commonly known as hot flashes or flushes and night sweats. BIJUVA is a once-daily combination of bioidentical estradiol and progesterone in a single oral capsule. The two hormones included in BIJUVA have the same structure as the hormones produced and circulating in a woman’s body.